ADAMTS5.md
... ...
@@ -23,10 +23,6 @@
23 23
|FL |No |No |2.666 |0.000 |
24 24
25 25
26
-> [!NOTE]
27
-> First described in BL in 2022 by [Burkhardt B](https://pubmed.ncbi.nlm.nih.gov/35794096)
28
-
29
-
30 26
View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ADAMTS5_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ADAMTS5_protein_hg38.html)
31 27
32 28
![image](images/proteinpaint/ADAMTS5_NM_007038.svg)
AGO4.md
... ...
@@ -23,9 +23,6 @@
23 23
|FL |No |No |0.000 | 0.000 |
24 24
25 25
26
-> [!NOTE]
27
-> First described in BL in 2022 by [Burkhardt B](https://pubmed.ncbi.nlm.nih.gov/35794096)
28
-
29 26
30 27
View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/AGO4_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/AGO4_protein_hg38.html)
31 28
ALPK2.md
... ...
@@ -23,9 +23,6 @@
23 23
|FL |No |No |1.538 |0 |
24 24
25 25
26
-> [!NOTE]
27
-> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468)
28
-
29 26
30 27
## ALPK2 Hotspots
31 28
ARHGEF1.md
... ...
@@ -23,9 +23,6 @@
23 23
|FL |No |No |3.865 |0.000 |
24 24
25 25
26
-> [!NOTE]
27
-> First described in BL in 2014 by [Muppidi JR](https://pubmed.ncbi.nlm.nih.gov/25274307)
28
-
29 26
30 27
View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ARHGEF1_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ARHGEF1_protein_hg38.html)
31 28
ARID1A.md
... ...
@@ -3,8 +3,6 @@
3 3
## Overview
4 4
ARID1A (AT-rich interactive domain-containing protein 1A) is a gene that encodes a subunit of the SWI/SNF chromatin remodeling complex, which is involved in regulating DNA accessibility. Mutations in ARID1A are implicated in various cancers, including B-cell lymphomas. They are the most abundant in Burkitt lymphoma but also occur in FL and, to a lesser extent, DLBCL.
5 5
6
-> [!NOTE]
7
-> Mutations in this gene were first described in BL in 2012 by [Love C](https://pubmed.ncbi.nlm.nih.gov/23143597) and first described in DLBCL in 2013 by [Zhang J](https://pubmed.ncbi.nlm.nih.gov/23292937)
8 6
9 7
## Relevance tier by entity
10 8
|Entity|Tier|Description |